Dr. Tina Q. Tan shares her COVID-19 vaccine hopes and her must-read articles from the May issue.
It is astonishing how fast 2021 is flying by—it is hard to believe that summer is almost here! On the COVID-19 vaccine front, clinical trials are being conducted in the pediatric population down to 6 months of age. With the encouraging preliminary results from the Pfizer/BioNTech COVID-19 vaccine clinical trials in children aged 12 to 15 years showing 100% efficacy, a vaccine may be available for those aged 12 years and older just in time for school. (Editor’s note: This article was written before the authorization of the vaccine for children aged 12 to 15 years.)
This month’s issue has several “must-read” articles covering topics that all of us in pediatric medicine encounter:
Thank you for providing outstanding care to your patients during these challenging times, and stay safe and well. How this anonymous quote rings true! “Always find time for things that make you feel happy to be alive.” And, as always, I welcome your suggestions, comments, and questions.
With warmest regards,
Tina Q. Tan
Having "the talk" with teen patients
June 17th 2022A visit with a pediatric clinician is an ideal time to ensure that a teenager knows the correct information, has the opportunity to make certain contraceptive choices, and instill the knowledge that the pediatric office is a safe place to come for help.
Meet the Board: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI
May 20th 2022Contemporary Pediatrics sat down with one of our newest editorial advisory board members: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI to discuss what led to her career in medicine and what she thinks the future holds for pediatrics.
Study finds reduced CIN3+ risk from early HPV vaccination
April 17th 2024A recent study found that human papillomavirus vaccination when aged under 20 years, coupled with active surveillance for cervical intraepithelial neoplasia grade 2, significantly lowers the risk of cervical intraepithelial neoplasia grade 3 or cervical cancer.